Clinical Trials Browser

Observational × Immunoglobulin Light-chain Amyloidosis × 90 days × Clear all

NCT07585331 2026-05-13

Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance

Immunoglobulin Light-chain Amyloidosis

NCT07448935 2026-05-06

ALPS

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, POEMS Syndrome

NCT04839003 2026-04-16

ReAL

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT06205953 2026-04-16

EUREKA

Immunoglobulin Light-chain Amyloidosis

NCT06383143 2026-04-16

ProDigALIty

Smoldering Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance

NCT05444920 2026-03-27

ITA-WebNet

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT01408225 2026-03-23

B-SCR-MM

Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias

NCT03431896 2026-03-12

MED-hATTR

Amyloidosis, Hereditary, Transthyretin-Related, Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis, Amyloid Neuropathies, Familial

NCT06627309 2026-03-09

Rapid dFLC Response Predict CHR in AL Amyloidosis

Immunoglobulin Light-chain Amyloidosis